Monkey Business: Canadian Government Published a Tender Notice for Smallpox Vaccine on April 21,2022
They must’ve had a crystal ball
Notice the closing date – exactly one week before the first monkeypox cases were reported by the WHO.
And if you refuse “safe and effective” smallpox vaccine, Mr. Tam might round you up and put a tracking bracelet on your arm to ensure compliance.
Forget the conspiracy theories, just roll up your sleeves for the FDA Approved Third Generation Smallpox Vaccine.
Its Safe and Effective:
“ Available human data on Jynneos administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.
The effect of Jynneos on embryo-fetal and post-natal development was evaluated in four developmental toxicity studies conducted in female rats and rabbits. In two studies, rats were administered a single human dose of Jynneos (0.5 mL) once prior to mating and on one or two occasions during gestation. In the third study, rats were administered a single human dose of Jynneos (0.5 mL) on two occasions during gestation. In the fourth study, rabbits were administered a single human dose of Jynneos (0.5 mL) once prior to mating and on two occasions during gestation. These animal studies revealed no evidence of harm to the fetus.”
“It is not known whether Jynneos is excreted in human milk. Data are not available to assess the effects of Jynneos in the breastfed infant or on milk production/excretion.”
Carcinogenesis, Mutagenesis, Impairment of Fertility
“Jynneos has not been evaluated for carcinogenic or mutagenic potential, or for impairment of male fertility in animals. Developmental toxicity studies conducted in rats and rabbits vaccinated with Jynneos revealed no evidence of impaired female fertility”.
“Safety and effectiveness of Jynneos have not been established in individuals less than 18 years of age.”
“Forty-two smallpox vaccine-experienced adults 65 to 80 years of age received at least one dose of Jynneos (Study 4).
Clinical studies of Jynneos did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”
Besides the above mentioned “benefits” it could also give you a smallpox …
Wait until millions of Immunocompromised Covid Jab victims will line up to get smallpox shots to save themselves from a “deadly” monkeyhoax.
God help us all…
Two corrupt companies were in rocky financial territory just a few weeks ago. Now, with concerns over a global monkeypox outbreak being hyped by media and global health organisations alike, the worries – and sins – of these two companies are quickly being forgotten
By Whitney Webb, 20 May 2022
In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organisation (“WHO”). For some, fears have centred around monkeypox being the potential “next pandemic” after Covid. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.
Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.
For these companies, the monkeypox fears are a godsend, specifically for SIGA, which produces a smallpox treatment, known by its brand name TPOXX. It is SIGA’s only product. While some outlets have noted that the rise in the valuation of SIGA Technologies has coincided with recent concerns about monkeypox, essentially no attention has been given to the fact that the company is apparently the only piece of a powerful billionaire’s empire that isn’t currently crumbling.
That billionaire, “corporate raider” Ron Perelman, has deep and controversial ties to the Clinton family and the Democratic party as well as troubling ties to Jeffery Epstein. Aside from his controlling stake in SIGA, Perelman has recently made headlines for rapidly liquidating many of his assets in a desperate bid for cash.
Similarly, Emergent Biosolutions have also been in hot water. The company, which has troubling ties to the 2001 Anthrax attacks, came under fire just under two weeks ago for engaging in a “cover-up” over quality control issues relating to their production of Covid vaccines. A Congressional investigation found that quality control concerns at an Emergent-run facility led to more than 400 million doses of Covid vaccines being discarded. The Emergent factory in question had been shut down by the FDA in April 2021. They were allowed to reopen last August before the government terminated the contract. Given that the majority of the company’s business is tied to US government contracts, the loss of this contract, and the accompanying poor publicity, the news that its smallpox vaccine may soon be of international interest is likely seen as a godsend by the company.
Notably, this is the second time in a year that both companies have benefitted from pandemic or bioterror fears propagated by the media. Last November, speculation rose that a re-emergence of the eradicated virus that causes smallpox would soon take place. This first began with Bill Gates’ comments on the prospects of smallpox bioterrorism during a 4 November 2021 interview and was followed by the 16 November announcement of a CDC/FBI investigation into 15 suspicious vials labelled “smallpox” at a Merck facility in Philadelphia. Now, roughly six months later, the same fears are again paying off for the same two companies.
It seems the fear being generated around monkeypox is not only boosting shares for these two rotten companies, but it’s also helping the public forget their past sins.
The above is the introduction to Whitney Webb’s article ‘Monkeypox Fears May Rescue Endangered Corporations’ published on Unlimited Hangout.
Read the full article HERE.
Scientists spread monkeypox amongst prairie dogs -spreads to mice
Follow the thread HERE
EcoHealth Alliance takes credit for spreading poxviruses to prairie dogs
Totally a coincidence
Here’s something interesting that is discussed on Twitter right now (hat tip Edward Dowd).
There was a monkeypox preparedness exercise held in March 2021.
Apparently, it “simulated” a start date of a pandemic, to be May 15, 2022.
Guess when the actual monkeypox media hype started this May? Around the same day!
The exercise “simulated” a vaccine-resistant monkeypox outbreak that was a biological warfare attack. Who were the participants? Same old people from the Bill and Melinda Gates Foundation, China CDC, and so on.
Lots of overlap between these participants and the infamous “Event 201” simulation, which also eerily predicted our Covid-19 pandemic. Chris Elias from BMGF, Mr. Gao from China CDC, and possibly more (I will update this paragraph). Here are the Event 201 participants, with the overlap highlighted:
I did not make the connection with Edward Dowd. He is the same Edward Dowd who has made explosive claims about economic collapse
Former BlackRock fund manager Edward Dowd has exploded on the “Team Reality” scene as of March 2022 due to his unique point of view on the unfolding COVID-19 saga. Like many other intelligent professionals from all walks of life, Dowd says he began to suspect something was wrong with “the narrative” early on. In fact, he even assembled a lengthy tweet thread outlining exactly how governments would respond to the “pandemic” in May of 2020 by couching his predictions as part of a “dystopian movie” plot. Then, when the “vaccines” became available to the public, he says he knew immediately something was wrong.